The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAFV600E Mutation

• Published in: OncoTargets and therapy Vol. 14; pp. 3959 - 3969
• Main Authors: Anekpuritanang, Tauangtham, Uataya, Maythad, Claimon, Apichaya, Laokulrath, Natthawadee, Pongsapich, Warut, Pithuksurachai, Paveena
• Format: Journal Article
• Language: English
• Published: Macclesfield Taylor & Francis Ltd 29.06.2021; Dove
• Subjects: Antibodies; Brain cancer; Cancer therapies; Graves disease; Hospitals; Immunohistochemistry; Kinases; Metastasis; Mutation; Original Research; Otolaryngology; Papillary thyroid carcinoma; Paraffin; Pathology; Patients; Proteins; Sodium; Sodium iodide symporter; Thyroid; Thyroid cancer; Thailand; United States > US; Bangkok Thailand

Objective: To study the association between radioiodine refractory papillary thyroid carcinoma, sodium/iodide symporter (NIS) expression, and the BRAFV600E mutation. Methods: A study was conducted on 30 radioiodine refractory papillary thyroid carcinoma patients and 30 radioiodine-avid papillary thy...